Top 10 Pharma Companies in Europe in 2021 by R&D Expenditure

GSK plc, UCB SA, Novartis AG, Bayer AG, and Novo Nordisk AS are the top 5 pharma companies in Europe in 2021 by R&D expenditure. In total, the top 10 pharma companies in Europe employed a total of 704,701 people in 2021. Europe-based F. Hoffmann-La Roche Ltd is one of the leading pharma companies in Europe by R&D expenditure. The company reported revenues of $68,710 million for the fiscal year ended December 2021 (FY2021), an increase of 7.7% over FY2020, due to an increase in sales from molecular lab, core lab, point of care, diabetes care, and pathology lab. The company is a biotechnology company that develops drugs and diagnostics to treat major diseases. It classifies its business into two segments: Pharmaceuticals and Diagnostics and employs 100,920 people. Novartis AG is one of the leading pharma companies in Europe by R&D expenditure. The company reported revenues of $52,877 million for the fiscal year ended December 2021 (FY2021), an increase of 6% over FY2020, due to an increase in product sales. The company is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic pharmaceutical products and eye care products. It classifies its business into two segments: Innovative Medicines and Sandoz and employs 108,000 people. Bayer AG is another leading pharma company in Europe by R&D expenditure. The company reported revenues of $52,124 million for the fiscal year ended December 2021 (FY2021), an increase of 6.5% over FY2020, due to growth in sales of COVID-19 related products and new product launches. The company is engaged in the discovery, development, manufacturing, and commercialization of products for human health, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications, which employs 101,914 people.